<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38248372</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-9721</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>11</Day></PubDate></JournalIssue><Title>Diseases (Basel, Switzerland)</Title><ISOAbbreviation>Diseases</ISOAbbreviation></Journal><ArticleTitle>Assessing the Quality of Life, Coping Strategies, Anxiety and Depression Levels in Patients with Long-COVID-19 Syndrome: A Six-Month Follow-Up Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diseases12010021</ELocationID><Abstract><AbstractText>This longitudinal study investigates the psychosocial effects of long-COVID Syndrome, a domain still not extensively researched. It specifically evaluates the quality of life, coping mechanisms, anxiety and depression levels in COVID-19 survivors, differentiating between those with and without long-COVID Syndrome. Conducted at the Victor Babes Hospital for Infectious Diseases and Pulmonology in Timisoara, Romania, the study utilized a cohort of patients diagnosed with mild to moderate COVID-19. The following standardized tools: WHOQOL-BREF for quality of life, COPE-60 for coping strategies, and the Hospital Anxiety and Depression Scale (HADS), were employed for the assessment. The sample consisted of 86 patients displaying persistent post-acute symptoms and 432 asymptomatic patients at the 6-month post-discharge mark. Patients with frequent post-acute symptoms reported significantly higher levels of fatigue (8.2 &#xb1; 1.4), cognitive difficulties (7.5 &#xb1; 1.6), and respiratory challenges (7.8 &#xb1; 1.3), along with a markedly lower overall quality of life (7.0 &#xb1; 1.5) compared to their asymptomatic counterparts. HADS scores revealed elevated depression (6.8 &#xb1; 1.9) and anxiety (7.1 &#xb1; 2.3) in the symptomatic group. Quality of life, as evaluated through the use of WHOQOL-BREF, showed lower scores in the symptomatic cohort across physical (58.8 &#xb1; 15.8), mental (56.3 &#xb1; 16.4), and social domains (50.2 &#xb1; 17.5). COPE-60 findings indicated a higher prevalence of disengagement (56.4%) and emotion-focused coping strategies (61.8%) in the symptomatic group, in contrast to 30.1% and 37.0%, respectively, in the asymptomatic group. The study highlights that long-COVID Syndrome significantly deteriorates the quality of life and is associated with increased depression and anxiety levels. The prevalent use of disengagement and emotion-focused coping strategies among patients with persistent symptoms suggests a need for enhanced psychosocial support tailored to this subgroup.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bota</LastName><ForeName>Adrian Vasile</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0003-0287-5938</Identifier><AffiliationInfo><Affiliation>Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bratosin</LastName><ForeName>Felix</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-4711-4315</Identifier><AffiliationInfo><Affiliation>Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogdan</LastName><ForeName>Iulia</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Septimiu-Radu</LastName><ForeName>Susa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilie</LastName><ForeName>Adrian Cosmin</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department III Functional Sciences, Division of Public Health and Management, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burtic</LastName><ForeName>Sonia-Roxana</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department II, Discipline of Medical Communication, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razvan</LastName><ForeName>David Vladut</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tudor</LastName><ForeName>Raluca</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1971-6901</Identifier><AffiliationInfo><Affiliation>Second Discipline of Neurology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Indries</LastName><ForeName>Mirela Florica</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Psycho-Neuroscience and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, Str. Universitatii nr. 1, 410087 Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csep</LastName><ForeName>Andrei Nicolae</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Psycho-Neuroscience and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, Str. Universitatii nr. 1, 410087 Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fildan</LastName><ForeName>Ariadna Petronela</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Faculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budea</LastName><ForeName>Camelia Melania</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0003-2242-5301</Identifier><AffiliationInfo><Affiliation>Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marincu</LastName><ForeName>Iosif</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diseases</MedlineTA><NlmUniqueID>101636232</NlmUniqueID><ISSNLinking>2079-9721</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>4</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38248372</ArticleId><ArticleId IdType="pmc">PMC10814582</ArticleId><ArticleId IdType="doi">10.3390/diseases12010021</ArticleId><ArticleId IdType="pii">diseases12010021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sharma A., Tiwari S., Deb M.K., Marty J.L. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies. Int. J. Antimicrob. Agents. 2020;56:106054. doi: 10.1016/j.ijantimicag.2020.106054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106054</ArticleId><ArticleId IdType="pmc">PMC7286265</ArticleId><ArticleId IdType="pubmed">32534188</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Rajnik M., Aleem A., Dulebohn S.C., Di Napoli R. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2023. Features, Evaluation, and Treatment of Coronavirus (COVID-19)</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis B., Bankhead-Kendall B.K., Dumas R.P. A review of COVID-19&#x2019;s impact on modern medical systems from a health organization management perspective. Health Technol. 2022;12:815&#x2013;824. doi: 10.1007/s12553-022-00660-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12553-022-00660-z</ArticleId><ArticleId IdType="pmc">PMC8956330</ArticleId><ArticleId IdType="pubmed">35371904</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc H.C., Xiao J., Liu W., Li Y., Chen G. Long COVID and its Management. Int. J. Biol. Sci. 2022;18:4768&#x2013;4780. doi: 10.7150/ijbs.75056.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Raveendran A.V., Giordano R., Arendt-Nielsen L. Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions. Microorganisms. 2023;11:2959. doi: 10.3390/microorganisms11122959.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11122959</ArticleId><ArticleId IdType="pmc">PMC10745830</ArticleId><ArticleId IdType="pubmed">38138102</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A., Theodoridou M., Maltezou H.C. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch. Med. Res. 2021;52:575&#x2013;581. doi: 10.1016/j.arcmed.2021.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Agarwal A., Alwan N., Luyckx V.A. Long COVID: Long-term health outcomes and implications for policy and research. Nat. Rev. Nephrol. 2023;19:1&#x2013;2. doi: 10.1038/s41581-022-00652-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-022-00652-2</ArticleId><ArticleId IdType="pmc">PMC9628426</ArticleId><ArticleId IdType="pubmed">36319780</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco J.V.A., Garegnani L.I., Oltra G.V., Metzendorf M.-I., Trivisonno L.F., Sgarbossa N., Ducks D., Heldt K., Mumm R., Barnes B., et al. Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map. Int. J. Environ. Res. Public Health. 2022;19:9915. doi: 10.3390/ijerph19169915.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19169915</ArticleId><ArticleId IdType="pmc">PMC9408764</ArticleId><ArticleId IdType="pubmed">36011562</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.W., Lagniton P.N., Liu Y., Xu R.-H. mRNA vaccines for COVID-19: What, why and how. Int. J. Biol. Sci. 2021;17:1446&#x2013;1460. doi: 10.7150/ijbs.59233.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.59233</ArticleId><ArticleId IdType="pmc">PMC8071766</ArticleId><ArticleId IdType="pubmed">33907508</ArticleId></ArticleIdList></Reference><Reference><Citation>Rzymski P., Kasianchuk N., Sikora D., Poniedzia&#x142;ek B. COVID-19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS-CoV-2 Omicron wave in the first quarter of 2022. J. Med. Virol. 2023;95:e28131. doi: 10.1002/jmv.28131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28131</ArticleId><ArticleId IdType="pmc">PMC9537885</ArticleId><ArticleId IdType="pubmed">36068643</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilches T.N., Sah P., Moghadas S.M., Shoukat A., Fitzpatrick M.C., Hotez P.J., Schneider E.C., Galvani A.P. COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA. Lancet Reg. Health Am. 2022;6:100147. doi: 10.1016/j.lana.2021.100147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2021.100147</ArticleId><ArticleId IdType="pmc">PMC8714489</ArticleId><ArticleId IdType="pubmed">34977848</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Chippa V., Aleem A., Anjum F. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2023. Post-Acute Coronavirus (COVID-19) Syndrome.</Citation><ArticleIdList><ArticleId IdType="pubmed">34033370</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucijani&#x107; M., &#x17d;ivkovi&#x107; N.P., Re&#x17e;i&#x107; T., Durlen I., Stoji&#x107; J., Jurin I., &#x160;akota S., Filipovi&#x107; D., Kurjakovi&#x107; I., Jordan A., et al. The performance of the WHO COVID-19 severity classification, COVID-GRAM, VACO Index, 4C Mortality, and CURB-65 prognostic scores in hospitalized COVID-19 patients: Data on 4014 patients from a tertiary center registry. Croat. Med. J. 2023;64:13&#x2013;20. doi: 10.3325/cmj.2023.64.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.3325/cmj.2023.64.13</ArticleId><ArticleId IdType="pmc">PMC10028560</ArticleId><ArticleId IdType="pubmed">36864814</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong F.Y., Yang L., Yuen J.W.M., Chang K.K.P., Wong F.K.Y. Assessing quality of life using WHOQOL-BREF: A cross-sectional study on the association between quality of life and neighborhood environmental satisfaction, and the mediating effect of health-related behaviors. BMC Public Health. 2018;18:1113. doi: 10.1186/s12889-018-5942-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-018-5942-3</ArticleId><ArticleId IdType="pmc">PMC6134517</ArticleId><ArticleId IdType="pubmed">30208869</ArticleId></ArticleIdList></Reference><Reference><Citation>Carver C.S. You want to measure coping but your protocol&#x2019;s too long: Consider the brief COPE. Int. J. Behav. Med. 1997;4:92&#x2013;100. doi: 10.1207/s15327558ijbm0401_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/s15327558ijbm0401_6</ArticleId><ArticleId IdType="pubmed">16250744</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziata M.A., Muzzatti B., Bidoli E., Flaiban C., Bomben F., Piccinin M., Gipponi K.M., Mariutti G., Busato S., Mella S. Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients. Support. Care Cancer. 2020;28:3921&#x2013;3926. doi: 10.1007/s00520-019-05244-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-019-05244-8</ArticleId><ArticleId IdType="pubmed">31858249</ArticleId></ArticleIdList></Reference><Reference><Citation>Samji H., Wu J., Ladak A., Vossen C., Stewart E., Dove N., Long D., Snell G. Review: Mental health impacts of the COVID-19 pandemic on children and youth&#x2014;A systematic review. Child Adolesc. Ment. Health. 2022;27:173&#x2013;189. doi: 10.1111/camh.12501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/camh.12501</ArticleId><ArticleId IdType="pmc">PMC8653204</ArticleId><ArticleId IdType="pubmed">34455683</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., Poletti S., Benedetti F. Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment. CNS Drugs. 2022;36:681&#x2013;702. doi: 10.1007/s40263-022-00931-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xed;&#x161;ka D., Liptakov&#xe1; E., Babi&#x10d;ov&#xe1; A., Batalik L., Ba&#x148;&#xe1;rov&#xe1; P.S., Dobrodenkov&#xe1; S. What is the quality of life in patients with long COVID compared to a healthy control group? Front. Public Health. 2022;10:975992. doi: 10.3389/fpubh.2022.975992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.975992</ArticleId><ArticleId IdType="pmc">PMC9667067</ArticleId><ArticleId IdType="pubmed">36408018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Bae S., Chang H.-H., Kim S.-W. Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. Sci. Rep. 2023;13:11207. doi: 10.1038/s41598-023-36995-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-36995-4</ArticleId><ArticleId IdType="pmc">PMC10336045</ArticleId><ArticleId IdType="pubmed">37433819</ArticleId></ArticleIdList></Reference><Reference><Citation>Betschart M., Rezek S., Unger I., Ott N., Beyer S., B&#xf6;ni A., Gisi D., Shannon H., Spruit M.A., Sieber C. One year follow-up of physical performance and quality of life in patients surviving COVID-19: A prospective cohort study. Swiss Med. Wkly. 2021;151:w30072. doi: 10.4414/SMW.2021.w30072.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/SMW.2021.w30072</ArticleId><ArticleId IdType="pubmed">34751538</ArticleId></ArticleIdList></Reference><Reference><Citation>Meys R., Delbressine J.M., Go&#xeb;rtz Y.M., Vaes A.W., Machado F.V., Van Herck M., Burtin C., Posthuma R., Spaetgens B., Franssen F.M., et al. Generic and respiratory-specific quality of life in non-hospitalized patients with COVID-19. J. Clin. Med. 2020;9:3993. doi: 10.3390/jcm9123993.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9123993</ArticleId><ArticleId IdType="pmc">PMC7764406</ArticleId><ArticleId IdType="pubmed">33317214</ArticleId></ArticleIdList></Reference><Reference><Citation>Malesevic S., Sievi N.A., Baumgartner P., Roser K., Sommer G., Schmidt D., Vallelian F., Jelcic I., Clarenbach C.F., Kohler M. Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19. Sci. Rep. 2023;13:7717. doi: 10.1038/s41598-023-34678-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-34678-8</ArticleId><ArticleId IdType="pmc">PMC10175927</ArticleId><ArticleId IdType="pubmed">37173355</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M., Moreno E., Cari&#xf1;ena A., Rey T., Pita-Romero R., Leal S., Sanduende Y., Rodr&#xed;guez A., Nieto C., Vilas E., et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br. J. Anaesth. 2021;126:e7&#x2013;e110. doi: 10.1016/j.bja.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., Patel U. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J. Med. Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Matud M. Gender differences in stress and coping styles. Pers. Individ. Differ. 2004;37:1401&#x2013;1415. doi: 10.1016/j.paid.2004.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.paid.2004.01.010</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>